The National Institute for Health and Clinical Excellence (NICE) has deferred its decision on whether or not it will update its guideline on CFS/M.E.
NICE posted the following notice on its website, 23 December:
“During the public consultation on NICE’s review proposal for clinical guideline 53 on the diagnosis and management of CFS/ME, a number of stakeholders advised that the results of the PACE trial are due to be published in 2011.
“As this significant trial may affect NICE’s final decision regarding whether its existing guideline warrants an update, NICE is deferring its announcement until further information is available.
“This is so that the conclusions made by NICE are as accurate and informed as possible.
“In the interests of high quality patient care, it is important that health professionals continue to adhere to the existing recommendations as they represent best clinical practice for the NHS.”
Action for M.E.’s response to the review consultation was published 15 November 2010.